BR100 Increased By (0.11%)
BR30 Decreased By (-0.26%)
KSE100 Increased By (0.12%)
KSE30 Increased By (0.09%)
AGHA 7.81 Increased By ▲ 0.06 (0.77%)
BECO 5.21 Increased By ▲ 0.02 (0.39%)
BML 57.50 Decreased By ▼ -1.16 (-1.98%)
BOP 34.03 Increased By ▲ 0.34 (1.01%)
CNERGY 9.96 Decreased By ▼ -0.65 (-6.13%)
CSIL 5.31 Increased By ▲ 0.01 (0.19%)
FCCL 54.70 Increased By ▲ 0.96 (1.79%)
FFL 16.69 Increased By ▲ 0.23 (1.4%)
FNEL 1.23 Increased By ▲ 0.01 (0.82%)
KEL 7.40 Increased By ▲ 0.12 (1.65%)
KOSM 5.77 Increased By ▲ 0.13 (2.3%)
LOTCHEM 29.32 Decreased By ▼ -0.33 (-1.11%)
MLCF 94.36 Decreased By ▼ -2.00 (-2.08%)
NBP 203.05 Decreased By ▼ -0.48 (-0.24%)
NCPL 57.00 Increased By ▲ 0.15 (0.26%)
NPL 67.70 Increased By ▲ 0.39 (0.58%)
OGDC 315.84 Decreased By ▼ -2.38 (-0.75%)
PACE 10.64 Increased By ▲ 0.01 (0.09%)
PAEL 43.20 Increased By ▲ 1.43 (3.42%)
PIBTL 16.74 Decreased By ▼ -0.07 (-0.42%)
PPL 219.78 Decreased By ▼ -0.39 (-0.18%)
PRL 49.19 Increased By ▲ 0.14 (0.29%)
PTC 70.53 Increased By ▲ 0.52 (0.74%)
SSGC 28.25 Decreased By ▼ -0.89 (-3.05%)
TBL 9.86 Increased By ▲ 0.09 (0.92%)
TELE 8.79 Decreased By ▼ -0.03 (-0.34%)
TPL 18.24 Increased By ▲ 1.07 (6.23%)
TPLP 13.27 Increased By ▲ 0.76 (6.08%)
TREET 22.72 Increased By ▲ 0.13 (0.58%)
TRG 60.14 Decreased By ▼ -0.08 (-0.13%)
World

Study finds 1 in 10 people in Spain has been infected with virus

  • The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.
Published Updated
By

MADRID: Around 4.7 million people in Spain, which amounts to one in 10 people, have contracted the coronavirus since the start of the pandemic, according to a new government-led antibody study.

The figure is significantly higher than the health ministry official tally, which now sits at 1.76 million. It is higher too than the estimate of over three million Covid-19 cases announced by Prime Minister Pedro Sanchez in October.

The sero-prevalence study, presented late on Tuesday, is now in its fourth round. Its work involved carrying out rapid antibody tests on 51,409 people across the country of some 47 million people between November 16 and 29.

The results of the previous round of the study, published in July, found a prevalence rate of just over 5.0 percent.

The infection rate in Madrid was the highest of all Spanish regions, with around 18 percent of the population testing positive for Covid-19 antibodies, against the national rate of 9.9 percent.

In contrast, regions such as the Canary Islands and Valencia in the east had a prevalence rate below 5.0 percent.

Comments

Comments are closed for this article.